Journal of Medical Virology,
Год журнала:
2022,
Номер
95(1)
Опубликована: Сен. 13, 2022
As
of
November
2021,
several
SARS-CoV-2
variants
appeared
and
became
dominant
epidemic
strains
in
many
countries,
including
five
concern
(VOCs)
Alpha,
Beta,
Gamma,
Delta,
Omicron
defined
by
the
World
Health
Organization
during
COVID-19
pandemic.
August
2022,
is
classified
into
main
lineages,
BA.1,
BA.2,
BA.3,
BA.4,
BA.5
some
sublineages
(BA.1.1,
BA.2.12.1,
BA.2.11,
BA.2.75,
BA.4.6)
(https://www.gisaid.org/).
Compared
to
previous
VOCs
(Alpha,
Delta),
all
lineages
have
most
highly
mutations
spike
protein,
with
50
accumulated
throughout
genome.
Early
data
indicated
that
BA.2
sublineage
had
higher
infectivity
more
immune
escape
than
early
wild-type
(WT)
strain,
VOCs,
BA.1.
Recently,
global
surveillance
suggest
a
transmissibility
BA.4/BA.5
BA.1.1
becoming
strain
countries
globally.
Immunological Reviews,
Год журнала:
2022,
Номер
310(1), С. 27 - 46
Опубликована: Июнь 22, 2022
Immunological
memory
is
the
basis
of
protective
immunity
provided
by
vaccines
and
previous
infections.
can
develop
from
multiple
branches
adaptive
immune
system,
including
CD4
T
cells,
CD8
B
long-lasting
antibody
responses.
Extraordinary
progress
has
been
made
in
understanding
to
SARS-CoV-2
infection
COVID-19
vaccines,
addressing
development;
quantitative
qualitative
features
different
cellular
anatomical
compartments;
durability
each
component
antibodies.
Given
sophistication
measurements;
size
human
studies;
use
longitudinal
samples
cross-sectional
head-to-head
comparisons
between
or
for
1
year
already
supersedes
that
any
other
acute
infectious
disease.
This
knowledge
may
help
inform
public
policies
regarding
as
well
scientific
development
future
against
diseases.
Journal of Infection and Public Health,
Год журнала:
2022,
Номер
16(1), С. 4 - 14
Опубликована: Ноя. 19, 2022
Newly
emerging
variants
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
are
continuously
posing
high
global
public
health
concerns
and
panic
resulting
in
waves
disease
2019
(COVID-19)
pandemic.
Depending
on
the
extent
genomic
variations,
mutations
adaptation,
few
gain
ability
to
spread
quickly
across
many
countries,
acquire
higher
virulency
cause
disease,
morbidity
mortality.
These
have
been
implicated
lessening
efficacy
current
COVID-19
vaccines
immunotherapies
break-through
viral
infections
vaccinated
individuals
recovered
patients.
Altogether,
these
could
hinder
protective
herd
immunity
be
achieved
through
ongoing
progressive
vaccination.
Currently,
only
variant
interest
SARS-CoV-2
is
Omicron
that
was
first
identified
South
Africa.
In
this
review,
we
present
overview
with
a
special
focus
variant,
its
lineages
hybrid
variants.
We
discuss
hypotheses
origin,
genetic
change
underlying
molecular
mechanism
behind
transmissibility
immune
escape
variant.
Major
related
including
available
immunotherapeutics
vaccines,
transmissibility,
severity,
mortality
discussed.
last
part,
challenges
strategies
counter
amid
pandemic
presented.
The
emergence
of
several
new
variants
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
in
recent
months
has
raised
concerns
around
the
potential
impact
on
ongoing
vaccination
programs.
Data
from
clinical
trials
and
real-world
evidence
suggest
that
current
vaccines
remain
highly
effective
against
alpha
variant
(B.1.1.7),
while
some
have
reduced
efficacy
effectiveness
symptomatic
disease
caused
by
beta
(B.1.351)
delta
(B.1.617.2);
however,
hospitalization
remains
high.
Although
data
primary
regimen
omicron
(B.1.1.529)
are
limited,
booster
programs
using
mRNA
been
shown
to
restore
protection
infection
(regardless
vaccine
used
for
regimen)
maintain
high
hospitalization.
However,
wanes
with
time
after
dose.
Studies
demonstrated
reductions
varying
magnitude
neutralizing
activity
vaccine-elicited
antibodies
a
range
SARS-CoV-2
variants,
particular
exhibiting
partial
immune
escape.
suggests
T-cell
responses
preserved
across
platforms,
regardless
concern.
Nevertheless,
various
mitigation
strategies
under
investigation
address
or
future
including
modification
certain
(including
omicron),
multivalent
formulations,
different
delivery
mechanisms.
Science,
Год журнала:
2022,
Номер
377(6608), С. 890 - 894
Опубликована: Июль 19, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Omicron
variant
of
concern
comprises
several
sublineages,
with
BA.2
and
BA.2.12.1
having
replaced
the
previously
dominant
BA.1
BA.4
BA.5
increasing
in
prevalence
worldwide.
We
show
that
large
number
sublineage
spike
mutations
leads
to
enhanced
angiotensin-converting
enzyme
(ACE2)
binding,
reduced
fusogenicity,
dampening
plasma
neutralizing
activity
elicited
by
infection
or
seven
clinical
vaccines
relative
ancestral
virus.
Administration
a
homologous
heterologous
booster
based
on
Wuhan-Hu-1
sequence
markedly
increased
antibody
titers
breadth
against
BA.1,
BA.2,
BA.2.12.1,
BA.4,
across
all
evaluated.
Our
data
suggest
although
sublineages
evade
polyclonal
responses
primary
vaccine
series,
boosters
may
provide
sufficient
protection
Omicron-induced
disease.
Journal of Biomedical Science,
Год журнала:
2022,
Номер
29(1)
Опубликована: Окт. 15, 2022
Abstract
Coronavirus
Disease
2019
(COVID-19)
has
been
the
most
severe
public
health
challenge
in
this
century.
Two
years
after
its
emergence,
rapid
development
and
deployment
of
effective
COVID-19
vaccines
have
successfully
controlled
pandemic
greatly
reduced
risk
illness
death
associated
with
COVID-19.
However,
due
to
ability
rapidly
evolve,
SARS-CoV-2
virus
may
never
be
eradicated,
there
are
many
important
new
topics
work
on
if
we
need
live
for
a
long
time.
To
end,
hope
provide
essential
knowledge
researchers
who
improvement
future
vaccines.
In
review,
provided
an
up-to-date
summary
current
vaccines,
discussed
biological
basis
clinical
impact
variants
subvariants,
analyzed
effectiveness
various
vaccine
booster
regimens
against
different
strains.
Additionally,
reviewed
potential
mechanisms
vaccine-induced
adverse
events,
summarized
studies
regarding
immune
correlates
protection,
finally,
next-generation
Cold Spring Harbor Perspectives in Medicine,
Год журнала:
2022,
Номер
12(5), С. a041390 - a041390
Опубликована: Апрель 20, 2022
Our
understanding
of
the
still
unfolding
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
pandemic
would
have
been
extremely
limited
without
study
genetics
and
evolution
this
new
human
coronavirus.
Large-scale
genome-sequencing
efforts
provided
close
to
real-time
tracking
global
spread
diversification
SARS-CoV-2
since
its
entry
into
population
in
late
2019.
These
data
underpinned
analysis
origins,
epidemiology,
adaptations
population:
principally
immune
evasion
increasing
transmissibility.
SARS-CoV-2,
despite
being
a
pathogen,
was
highly
capable
human-to-human
transmission.
During
rapid
humans,
has
evolved
independent
forms,
so-called
"variants
concern,"
that
are
better
optimized
for
The
most
important
adaptation
bat
progenitor
both
SARS-CoV-1
infection
(and
other
mammals)
is
use
angiotensin-converting
enzyme
(ACE2)
receptor.
Relaxed
structural
constraints
provide
plasticity
SARS-related
spike
protein
permitting
it
accommodate
significant
amino
acid
replacements
antigenic
consequence
compromising
ability
bind
ACE2.
Although
bulk
research
justifiably
concentrated
on
viral
as
main
determinant
changes
transmissibility,
there
accumulating
evidence
contribution
regions
proteome
virus-host
interaction.
Whereas
levels
community
transmission
recombinants
genetically
distinct
variants
at
present
low,
when
divergent
cocirculate,
recombination
between
clades
detected,
risk
viruses
with
properties
emerge.
Applying
computational
machine
learning
methods
genome
sequence
sets
generate
experimentally
verifiable
predictions
will
serve
an
early
warning
system
novel
variant
surveillance
be
future
vaccine
planning.
Omicron,
latest
concern,
focused
attention
step
change
events,
"shift,"
opposed
incremental
"drift"
antigenicity.
Both
increase
transmissibility
shift
Omicron
led
readily
causing
infections
fully
vaccinated
and/or
previously
infected.
Omicron's
virulence,
while
reduced
relative
concern
replaced,
Delta,
very
much
premised
past
exposure
individuals
clear
signal
boosted
vaccination
protects
from
disease.
Currently,
proven
itself
dangerous
pathogen
unpredictable
evolutionary
capacity,
leading
too
great
not
ensure
all
world
screened
by
sequencing,
protected
through
available
affordable
vaccines,
non-punitive
strategies
place
detecting
responding
concern.